MARKER THERAPEUTICS (MRKR)
(Delayed Data from NSDQ)
$1.19 USD
-0.04 (-3.25%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $1.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
MARKER THERAPEUTICS, INC.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
MRKR 1.19 -0.04(-3.25%)
Will MRKR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MRKR based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for MRKR
Marker Therapeutics to Participate in a Fireside Chat at the Canaccord Genuity 45th Annual ...
12 Health Care Stocks Moving In Thursday's Intraday Session
Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Strategic Collaborations and Promising Clinical Developments Drive Buy Rating for Marker Therapeutics